Saracatinib as a Metastasis Inhibitor in Metastatic Castration-Resistant Prostate Cancer: A University of Chicago Phase 2 Consortium and DOD/PCF Prostate Cancer Clinical Trials Con...

Por Posadas, Edwin M., Ahmed, Rafi S., Karrison, Theodore, Szmulewitz, Russell Z., O’Donnell, Peter H., Wade, James L., Shen, James, Gururajan, Murali, Sievert, Margarit, Stadler, Walter M.
Publicado no Prostate (2015)

Fyn is downstream of the HGF/MET signaling axis and affects cellular shape and tropism in PC3 cells

Por Jensen, Ana R., Saito, Y. David, Liao, Chuanhong, Dai, Jinlu, Keller, Evan T., Al-Ahmadie, Hikmat, Haché, Kelly Dakin, Usatyuk, Peter, Sievert, Margarit, Paner, Gladell P., Yala, Soheil, Cervantes, Gustavo M., Natarajan, Viswanathan, Salgia, Ravi, Posadas, Edwin M.
Publicado em 2011

SRC family kinase FYN promotes the neuroendocrine phenotype and visceral metastasis in advanced prostate cancer

Por Gururajan, Murali, Cavassani, Karen A., Sievert, Margarit, Duan, Peng, Lichterman, Jake, Huang, Jen-Ming, Smith, Bethany, You, Sungyong, Nandana, Srinivas, Chu, Gina Chia-Yi, Mink, Sheldon, Josson, Sajni, Liu, Chunyan, Morello, Matteo, Jones, Lawrence W. M., Kim, Jayoung, Freeman, Michael R., Bhowmick, Neil, Zhau, Haiyen E., Chung, Leland W.K., Posadas, Edwin M.
Publicado no Oncotarget (2015)